Does Innovation Input Affect Innovation Output? Empirical Findings on the Linkage of Pharmaceutical R&D Expenditures to Total Patents and Health Patents in Türkiye
Öz
The pharmaceutical and pharmacy sector in Türkiye, which is critically important for the production and development of high value-added products, aims to increase its international competitiveness by leading the introduction of new products to the market through R&D investments and ensuring sustainable growth. This study examines the impact of R&D investments in the pharmaceutical and pharmacy sector in Türkiye on patent production capacity for the period 1980-2020 using the ARDL (Autoregressive Distributed Lag) method. The findings reveal a long-term relationship between the variables, and long-term predictions show that pharmaceutical R&D expenditures positively affect both total patent applications and health-related patent applications. Furthermore, the number of personnel engaged in R&D activities significantly impacts both total and health-related patent applications. The study demonstrates that the innovation potential in the health sector is closely related to health R&D investments and the number of personnel involved in R&D activities.
Anahtar Kelimeler
Pharmaceutical R&D Expenditures, Innovation Economics, Health Economics, Time Series Analysis
Destekleyen Kurum
TÜBİTAK/This study was supported by TUBITAK (the Scientific and Technological Research Council of Turkey). TUBITAK-ARDEB 1004 Research Project No: 20AG006.
Proje Numarası
20AG006
Etik Beyan
This study has been prepared in accordance with the rules of scientific research and publication ethics.
Kaynakça
- Acs, Z. J., & Audretsch, D. B. (1988). Innovation in large and small firms: An empirical analysis. American Economic Review, 78(4), 678–690.
- Akarsu, Y. (2020). Patent Başvurularının Türkiye’nin İhracatına Etkisi. Journal of International Management Educational and Economics Perspectives, 8(2), 110–124.
- Akpınar, A., & Çelik, N. (2025). OECD Ülkelerinde Cari Açık Sorunu ve Çözüm Önerileri: DFE-ARDL Panel Model Bulguları. Dokuz Eylül Üniversitesi İşletme Fakültesi Dergisi, 26(1), 46-66.
- Belitski, M., Delgado‐Márquez, B. L., & Pedauga, L. E. (2024). Your innovation or mine? The effects of partner diversity on product and process innovation. Journal of Product Innovation Management, 41(1), 112-137.
- Bloom, N., Jones, C. I., Van Reenen, J., & Webb, M. (2020). Are ideas getting harder to find?. American Economic Review, 110(4), 1104-1144.
- Bolívar-Ramos, M. T. (2017). The relation between R&D spending and patents: The moderating effect of collaboration networks. Journal of Engineering and Technology Management, 46, 26-38.
- Chang-Muñoz, E. A., Guarín-García, A. F., Charris-Sevilla, Y., Gallego-Nicholls, J. F., Santos-Rojo, C., & Ortigosa-Blanch, A. (2023). Innovation activities and their impact on product innovation results: evidence from a sectorial study. Sustainability, 15(8), 6459.
- Chen, Z., Zhang, J., & Zi, Y. (2021). A cost-benefit analysis of R&D and patents: Firm-level evidence from China. European Economic Review, 133, 103633.
- Cockburn, I. M., & Henderson, R. M. (2001). Scale and scope in drug development: Unpacking the advantages of size in pharmaceutical research. Journal of Health Economics, 20(6), 1033–1057.
- Das, R. C. (2020). Interplays among R&D spending, patent and income growth: New empirical evidence from the panel of countries and groups. Journal of Innovation and Entrepreneurship, 9(1), 18.